Agreement with Robotic Biology Institute to Jointly Sell an Integrated Solution for Cell Culture Automation and Optimization
Epistra, Inc. has agreed with Robotic Biology Institute, Inc. (hereinafter RBI) to jointly sell an integrated solution for cell culture automation and optimization.
According to OECD projections, the global regenerative medicine market is expected to reach approximately 1 trillion yen by 2030.
Solution Overview
This solution combines the automation of cell culture experiments using RBI’s humanoid robot “LabDroid Mahoro” with the optimization of culture conditions using Epistra’s automated experimental design AI “Epistra Accelerate.”
- LabDroid “Mahoro”: A humanoid robot system with two arms that possesses dexterity equivalent to humans, executing cell culture operations with precision and high reproducibility
- Epistra Accelerate: An AI system designed to discover optimal culture conditions with fewer experimental trials
The memorandum of understanding was signed on January 1, 2023.
Company Information
- Epistra, Inc.: Founded March 2018, Minato-ku, Tokyo
- Robotic Biology Institute, Inc.: Koto-ku, Tokyo
Related Articles
Epistra Contributes Article on "AI-Robot-Driven Drug Development" to Pharmacia, Journal of the Pharmaceutical Society of Japan
Epistra CTO Taku Tsuzuki and CEO Yosuke Ozawa contributed an article on AI-robot-driven drug development to Pharmacia, Vol. 62 No. 7, published by the Pharmaceutical Society of Japan.
Cell Culture Optimization Software 'CellTune Ver.2' Launches Globally
Epistra Inc. announces the global launch of 'CellTune Ver.2,' the updated version of the co-developed cell culture optimization software with Shimadzu Corporation, on June 29, 2026. The new version introduces cloud-based subscription delivery and overseas expansion of custom media manufacturing services.
Speaking Engagement: CEO Yosuke Ozawa Presented at the 10th Shonan iPark Regenerative Medicine Seminar
On June 3, 2026, Epistra Inc. CEO Yosuke Ozawa presented at the 10th Shonan iPark Regenerative Medicine Seminar, sharing implementation case studies and future prospects for AI and mathematical optimization in regenerative medicine process development.